1. Home
  2. TCPC vs TMCI Comparison

TCPC vs TMCI Comparison

Compare TCPC & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock TCP Capital Corp.

TCPC

BlackRock TCP Capital Corp.

N/A

Current Price

$4.00

Market Cap

346.5M

Sector

Finance

ML Signal

N/A

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

N/A

Current Price

$4.53

Market Cap

279.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TCPC
TMCI
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
346.5M
279.6M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
TCPC
TMCI
Price
$4.00
$4.53
Analyst Decision
Sell
Hold
Analyst Count
2
6
Target Price
$3.50
$4.77
AVG Volume (30 Days)
632.9K
221.8K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
18.23%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$212,690,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$8.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.59
52 Week Low
$3.08
$1.17
52 Week High
$6.79
$7.42

Technical Indicators

Market Signals
Indicator
TCPC
TMCI
Relative Strength Index (RSI) 40.71 49.78
Support Level $3.67 $4.25
Resistance Level $3.98 $4.86
Average True Range (ATR) 0.08 0.22
MACD -0.05 -0.02
Stochastic Oscillator 15.96 41.38

Price Performance

Historical Comparison
TCPC
TMCI

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve its investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights, or direct equity investments.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

Share on Social Networks: